Cite
APA Citation
Carbery, I., Broglio, G., Clark, T., Greer, D., Alakkari, A., & Selinger, C. P. (n.d.). p731 Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13). Journal of Crohn's and colitis, 17, i861. http://access.bl.uk/ark:/81055/vdc_100179844380.0x00003d